Short answer
Aurinia Pharmaceuticals Inc. (AUPH) filed an 8-K current report with the SEC on June 4, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Shareholders re-elected five directors through 2027, with support ranging from 86.50% to 96.59%.
Aurinia Pharmaceuticals Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Shareholders re-elected five directors through 2027, with support ranging from 86.50% to 96.59%
- Craig Johnson and Tina S. Nova received comparatively weaker support, at 86.50% and 86.89%
- PricewaterhouseCoopers LLP approved as independent auditor through 2027, with 89.14% support
- Executive compensation received strong non-binding approval, with 93.10% voting in favor of say-on-pay
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Aurinia Pharmaceuticals Inc. 8-K filings
Get the next AUPH 8-K as it lands
Follow AUPH for push alerts, or ask the research agent what this filing means.